Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
lebrikizumab-lbkz bulk supplier for pharma manufacturers

Lebrikizumab-Lbkz 250mg/2ml Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 250mg/2ml

Reference Brands: Ebglyss (USA/EU)

Category: Derma Drugs

Lebrikizumab-lbkz is used for the treatment of moderate to severe atopic dermatitis (eczema) in adults and adolescents who are not adequately controlled with topical treatments. It works by inhibiting interleukin-13 (IL-13), a key cytokine involved in skin inflammation.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Lebrikizumab-Lbkz — third party manufacturing & bulk supply

Lebrikizumab-Lbkz 250mg/2ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lebrikizumab-Lbkz is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lebrikizumab-Lbkz listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lebrikizumab-Lbkz →
Back to Listing

Frequently Asked Questions

lebrikizumab-lbkz is listed as Injection in 250mg/2ml. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

lebrikizumab-lbkz is referenced against Ebglyss (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Sofpironium Bromide

Strength:
5%, 12.45%

Form: Topical Gel

Reference Brands: ECCLOCK, Sofdra

View Details
Sarecycline

Strength:
60 mg, 100 mg, 150 mg

Form: Tablets

Reference Brands: Seysara (USA)

View Details
Afamelanotide

Strength:
16 mg

Form: Subcutaneous implant

Reference Brands: Scenesse (USA)

View Details
Glycopyrronium Tosylate

Strength:
2.4%

Form:

Reference Brands: Qbrexza (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.